Important: The POPLINE website will retire on September 1, 2019. Click here to read about the transition.

Your search found 2 Results

  1. 1
    331506

    How to be reasonably sure a client is not pregnant. [Checklist].

    Family Health International [FHI]

    Research Triangle Park, North Carolina, FHI, 2008. [2] p.

    In order to help nonmenstruating clients safely initiate their method of choice, Family Health International (FHI) developed a simple checklist for use by family planning providers. Although originally the Pregnancy Checklist was developed for use by family planning providers, it can also be used by other health care providers who need to determine whether a client is not pregnant. For example, pharmacists may use this checklist when prescribing certain medications that should be avoided during pregnancy (e.g., certain antibiotics or anti-seizure drugs). The checklist is endorsed by the World Health Organization (WHO) and is based on criteria established by WHO for determining with reasonable certainty that a woman is not pregnant. Evaluation of the checklist in family planning clinics has demonstrated that the tool is very effective in correctly identifying women who are not pregnant. Furthermore, recent studies in Guatemala, Mali, and Senegal have shown that use of the checklist by family planning providers significantly reduced the proportion of clients being turned away due to menstrual status and improved women's access to contraceptive services.
    Add to my documents.
  2. 2
    108519
    Peer Reviewed

    [Indications and contraindications of contraception: a new approach] Indications et contre-indications de la contraception: nouvelle approche.

    Benagiano G; Turmen T

    BULLETIN OF THE WORLD HEALTH ORGANIZATION. 1995; 73(2):269-70.

    In March 1994, WHO hosted a Meeting on Improving Access to Quality Care in Family Planning in Geneva, Switzerland. Participants reviewed the most recent scientific data on indications and contraindications among new acceptors of combined oral contraceptives, progestin-only pills, progestogen injectables (Depo-Provera), contraceptive implants (Norplant), and copper releasing IUDs. They proposed a new classification system to help family planning providers and new acceptors decide on a contraceptive method. It is based on an evaluation of the risks and benefits associated with the condition or current characteristics of the woman. The approach is comparable to that used to regulate traffic. The association between a condition or particular characteristics allows the placement of a given method in one of the following categories: no restriction of use (green light); advantages generally exceed the risks (orange light); the risks usually exceed the benefits and the method must not be used, except in the case where more appropriate methods are neither available nor acceptable (flashing red light); and the method must not be used at all (red light). Community-based distribution programs or health agents providing family planning services can distribute contraceptives fitting into the first two categories. Work has begun on contraceptive methods not considered at the March 1994 meeting. The recommendations from the March 1994 meeting can be ordered from the Family Health Division, WHO, 1211 Geneva 27, Switzerland.
    Add to my documents.